Use of a predictive model derived from in vivo endophenotype measurements to demonstrate associations with a complex locus, CYP2A6

Human Molecular Genetics

Volumn 21, Issue 13, 2012, Pages 3050-3062

  Bloom, A Joseph ^a   Harari, Oscar ^a   Martinez, Maribel ^a   Madden, Pamela A F ^a   Martin, Nicholas G ^b   Montgomery, Grant W ^b   Rice, John P ^a   Murphy, Sharon E ^c   Bierut, Laura J ^a   Goate, Alison ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2A6; NICOTINE;

AFRICAN AMERICAN; ALLELE; ARTICLE; CIGARETTE SMOKING; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; ENDOPHENOTYPE; EUROPEAN AMERICAN; FAGERSTROM TEST OF NICOTINE DEPENDENCE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; IN VIVO STUDY; METABOLISM; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TOBACCO DEPENDENCE;

AFRICAN AMERICANS; ALLELES; ARYL HYDROCARBON HYDROXYLASES; ENDOPHENOTYPES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GENOTYPE; HUMANS; NICOTINE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING;

EID: 84863502226     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds114     Document Type: Article

References (34)

1. Schoedel, K.A., Hoffmann, E.B., Rao, Y., Sellers, E.M. and Tyndale, R.F. (2004) Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics, 14, 615-626.
2. Benowitz, N.L., Pomerleau, O.F., Pomerleau, C.S. and Jacob, P. 3rd. (2003) Nicotine metabolite ratio as a predictor of cigarette consumption. Nicotine Tob. Res., 5, 621-624.
3. Jarvik, M.E., Madsen, D.C., Olmstead, R.E., Iwamoto-Schaap, P.N., Elins, J.L. and Benowitz, N.L. (2000) Nicotine blood levels and subjective craving for cigarettes. Pharmacol. Biochem. Behav., 66, 553-558.
4. Strasser, A.A., Lerman, C., Sanborn, P.M., Pickworth, W.B. and Feldman, E.A. (2007) New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure. Drug Alcohol Depend., 86, 294-300.
5. Hatsukami, D.K., Lemmonds, C., Zhang, Y., Murphy, S.E., Le, C., Carmella, S.G. and Hecht, S.S. (2004) Evaluation of carcinogen exposure in people who used 'reduced exposure' tobacco products. J. Natl Cancer Inst., 96, 844-852.
6. Bloom, J., Hinrichs, A.L., Wang, J.C., von Weymarn, L.B., Kharasch, E.D., Bierut, L.J., Goate, A. and Murphy, S.E. (2011) The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans. Pharmacogenet. Genomics, 21, 403-416.
7. Hukkanen, J., Jacob, P. 3rd and Benowitz, N.L. (2005) Metabolism and disposition kinetics of nicotine. Pharmacol. Rev., 57, 79-115.
8. Audrain-McGovern, J., Al Koudsi, N., Rodriguez, D., Wileyto, E.P., Shields, P.G. and Tyndale, R.F. (2007) The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics, 119, e264-e274.
9. O'Loughlin, J., Paradis, G., Kim, W., DiFranza, J., Meshefedjian, G., McMillan-Davey, E., Wong, S., Hanley, J. and Tyndale, R.F. (2004) Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers. Tob. Control, 13, 422-428.
10. Thorgeirsson, T.E., Gudbjartsson, D.F., Surakka, I., Vink, J.M., Amin, N., Geller, F., Sulem, P., Rafnar, T., Esko, T., Walter, S. et al. (2010) Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat. Genet., 42, 448-453.
11. Tobacco and Genetics Consortium. (2010) Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet., 42, 441-447.
12. Pomerleau, O.F., Collins, A.C., Shiffman, S. and Pomerleau, C.S. (1993) Why some people smoke and others do not: new perspectives. J. Consult. Clin. Psychol., 61, 723-731.
13. Malaiyandi, V., Sellers, E.M. and Tyndale, R.F. (2005) Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. Clin. Pharmacol. Ther., 77, 145-158.
14. Liu, T., David, S.P., Tyndale, R.F., Wang, H., Zhou, Q., Ding, P., He, Y.H., Yu, X.Q., Chen, W., Crump, C. et al. (2011) Associations of CYP2A6 genotype with smoking behaviors in southern China. Addiction, 106, 985-994.
15. Malaiyandi, V., Lerman, C., Benowitz, N.L., Jepson, C., Patterson, F. and Tyndale, R.F. (2006) Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. Mol. Psychiatry, 11, 400-409.
16. Dickson, S.P., Wang, K., Krantz, I., Hakonarson, H. and Goldstein, D.B. (2010) Rare variants create synthetic genome-wide associations. PLoS Biol., 8, e1000294.
17. Goldstein, D.B. (2011) The importance of synthetic associations will only be resolved empirically. PLoS Biol., 9, e1001008.
18. Do, C.B. and Batzoglou, S. (2008) What is the expectation maximization algorithm? Nat. Biotechnol., 26, 897-899.
19. Yamano, S., Tatsuno, J. and Gonzalez, F.J. (1990) The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry, 29, 1322-1329.
20. Gertz, J., Gerke, J.P. and Cohen, B.A. (2010) Epistasis in a quantitative trait captured by a molecular model of transcription factor interactions. Theor. Popul. Biol., 77, 1-5.
21. Al Koudsi, N., Hoffmann, E.B., Assadzadeh, A. and Tyndale, R.F. (2010) Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors. Eur. J. Clin. Pharmacol., 66, 239-251.
22. Fukami, T., Nakajima, M., Higashi, E., Yamanaka, H., McLeod, H.L. and Yokoi, T. (2005) A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity. Biochem. Pharmacol., 70, 801-808.
23. Ho, M.K., Mwenifumbo, J.C., Zhao, B., Gillam, E.M. and Tyndale, R.F. (2008) A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent. Pharmacogenet. Genomics, 18, 67-75.
24. Mwenifumbo, J.C., Al Koudsi, N., Ho, M.K., Zhou, Q., Hoffmann, E.B., Sellers, E.M. and Tyndale, R.F. (2008) Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent. Hum. Mutat., 29, 679-688.
25. von Richter, O., Pitarque, M., Rodriguez-Antona, C., Testa, A., Mantovani, R., Oscarson, M. and Ingelman-Sundberg, M. (2004) Polymorphic NF-Y dependent regulation of human nicotine C-oxidase (CYP2A6). Pharmacogenetics, 14, 369-379.
26. Haberl, M., Anwald, B., Klein, K., Weil, R., Fuss, C., Gepdiremen, A., Zanger, U.M., Meyer, U.A. and Wojnowski, L. (2005) Three haplotypes associated with CYP2A6 phenotypes in Caucasians. Pharmacogenet. Genomics, 15, 609-624.
27. Fukami, T., Nakajima, M., Yamanaka, H., Fukushima, Y., McLeod, H.L. and Yokoi, T. (2007) A novel duplication type of CYP2A6 gene in African-American population. Drug Metab. Dispos., 35, 515-520.
28. Tyndale, R.F. and Sellers, E.M. (2001) Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk. Drug Metab. Dispos., 29, 548-552.
29. Bierut, L.J., Madden, P.A., Breslau, N., Johnson, E.O., Hatsukami, D., Pomerleau, O.F., Swan, G.E., Rutter, J., Bertelsen, S., Fox, L. et al. (2007) Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum. Mol. Genet., 16, 24-35.
30. Saccone, N.L., Wang, J.C., Breslau, N., Johnson, E.O., Hatsukami, D., Saccone, S.F., Grucza, R.A., Sun, L., Duan, W., Budde, J. et al. (2009) The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Cancer Res., 69, 6848-6856.
31. Saccone, S.F., Hinrichs, A.L., Saccone, N.L., Chase, G.A., Konvicka, K., Madden, P.A., Breslau, N., Johnson, E.O., Hatsukami, D., Pomerleau, O. et al. (2007) Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum. Mol. Genet., 16, 36-49.
32. Saccone, S.F., Pergadia, M.L., Loukola, A., Broms, U., Montgomery, G.W., Wang, J.C.,Agrawal,A., Dick,D.M., Heath, A.C., Todorov,A.A. et al. (2007) Genetic linkage to chromosome 22q12 for a heavy-smoking quantitative trait in two independent samples. Am. J. Hum. Genet., 80, 856-866.
33. Saccone,N.L., Saccone, S.F., Hinrichs,A.L., Stitzel, J.A.,Duan, W., Pergadia, M.L., Agrawal, A., Breslau, N., Grucza, R.A., Hatsukami, D. et al. (2009) Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am. J. Med. Genet. B Neuropsychiatr. Genet., 150B, 453-466.
34. Barrett, J.C., Fry, B., Maller, J. and Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.